← FDA DRUG APPROVALS

FDA ANDA · ANDA074898

IOPAMIDOL-300

Sponsor: HOSPIRA

APPLICATION
ANDA074898
TYPE
ANDA
ORIGINAL APPROVAL
1997-12-30
LATEST ACTION
2002-11-01
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

IOPAMIDOL-300Discontinued
IOPAMIDOL 61% · INJECTABLE · INJECTION
IOPAMIDOL-200Discontinued
IOPAMIDOL 41% · INJECTABLE · INJECTION
IOPAMIDOL-370Discontinued
IOPAMIDOL 76% · INJECTABLE · INJECTION
IOPAMIDOL-250Discontinued
IOPAMIDOL 51% · INJECTABLE · INJECTION

Approval history

2002-11-01Manufacturing (CMC) · Supplement 1AP
1997-12-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →